Pantoprazole 40 Mg Pd 40 mg Gastro-resistant tablet.
PDF Leaflet Revision Date: 05 November 2024
Clinical Summary
Quick overview from the medicine insert
Indication
Short-term treatment of duodenal ulcer, gastric ulcer, reflux oesophagitis, and Zollinger-Ellison Syndrome.
Dosage (summary)
40 mg once daily for duodenal/gastric ulcers and reflux; 80 mg for Zollinger-Ellison Syndrome.
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Avoid in pregnancy; breastfeeding not recommended due to potential risk.
Key Drug Interactions
- Warfarin
- Atazanavir
- Methotrexate
Contraindications
- Hypersensitivity to pantoprazole
- Severe liver impairment
- Children
Common side effects
- Headache
- Dizziness
- Nausea
- Diarrhoea
Counselling Points
- Take before breakfast
- Monitor for gastrointestinal symptoms
- Report any unusual symptoms promptly
Serious warnings
- Risk of Clostridium difficile-associated diarrhoea
- Potential for hypomagnesaemia
- Increased risk of bone fractures
Important Disclaimer
The Pantoprazole 40 Mg Pd 40 mg Gastro-resistant tablet. professional information leaflet below is the property of Pharma Dynamics and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
